Connect with us

UK / EU Cannabis Compliance

Article: Nearly 3,000 products advance in UK’s $800 million CBD sweepstakes

Published

on


Hemp Today reports

The UK Food Standards Agency (FSA) has now advanced a total 2,847 CBD products to the second stage of its three-stage approval process for new (or “novel”) foods. In the most recent development, 2,692 CBD isolate products submitted in a joint application from EIHA projects GmbH, a consortium of the European Industrial Hemp Association, were moved to the “validated” category on the FSA’s register.

FSA is sorting out applications for roughly 12,000 individual products as it works to clarify a flourishing gray market that has seen retail outlets flooded with CBD products over the past several years, raising safety concerns.

The EIHA consortium has another 2,205 products in a second application for CBD distillates which remains at the first stage of the FSA’s review, “awaiting evidence.”

A second consortium organized under the UK’s Association for the Cannabinoids Industry (ACI) also had products in a joint application recently “validated” by the FSA. Those applications cover 29 isolate and distillate products but ACI said they could carry the fate of up to 4,000 products.

The validated products now face safety assessment based on reviews for toxicology and other technical benchmarks.

400 products removed

A total of 400 product applications are now in the “removed” category and are no longer in the running to receive market approval. FSA does not disclose the causes for removals, but has said they reflect withdrawal by applicants, or that the products in some way failed to meet the agency’s criteria. Products struck from the list may no longer be offered to consumers under FSA rules.

More than 300 product applications that have been removed were from JM Wholesale Ltd. of the UK. But that company still has more than 400 products that continue in the first stage of the review. British Cannabis, which submitted the most products (1,471) to the FSA review process, has seen 15 products disqualified; and RX Pharmatech, the No. 2 applicant (801), had eight fall off the list but still has nearly 800 in contention.

To get onto the FSA’s public list of CBD products – and therefore remain on the market pending final approval – products already in distribution had to have been on sale before Feb. 13, 2020. Those introduced to the market after that date were not eligible for the agency’s consideration.

FSA’s challenge

FSA was inundated with CBD applications early last year after stakeholders complained about the review process that guides the one-time chance for producers to get their gray-market products legal. The agency eventually reopened the application window by one full year, which eventually brought a flood of products to the list, nearly quadrupling the original number under review from roughly 3,500 to more than 12,000.

FSA said it expects the first CBD products to be fully authorized during the latter half of 2023 if the evidence necessary for safety assessments is complete. The authorization process can take more time if additional studies are required, according to the agency.

ACI has estimated the domestic CBD market at roughly £690 million ($830 million/€785 million).

Source:  https://hemptoday.net/nearly-3000-products-advance-in-uks-800-million-cbd-sweepstakes/



Source link

Continue Reading

UK / EU Cannabis Compliance

German Medical Cannabis Associations Call For Wider Regulatory Reform

Published

on

By


In July 2023, Germany’s federal government commissioned the Federal Joint Committee (G-BA) – the body responsible for determining which medical treatments are covered by the country’s statutory health insurance – to amend the current regulations around medical cannabis prescriptions.

The G-BA is in the process of deciding four specialist areas for which the current approval requirement should no longer apply, making it easier to obtain insurance coverage for the medicine.

However, the country’s medical cannabis associations say this does not go far enough and have called for the approval requirement to be removed for all conditions in which cannabis has shown medical efficacy.

Medical cannabis has been legal in Germany since 2017 and can be prescribed by any doctor for patients with serious medical conditions. It is one of the few countries globally where the treatment can be covered under the public health insurance system in certain cases.

But currently, for patients with statutory health insurance, the costs of medical cannabis are only covered if previously approved by the insurance company.

This application process is said to be ‘daunting, lengthy and bureaucratic’ for doctors and patients, with 30-40% of applications being rejected.

https://businessofcannabis.com/german-medical-cannabis-associations-call-for-wider-regulatory-reform/



Source link

Continue Reading

UK / EU Cannabis Compliance

Portugal: Full Legalisation on the Horizon?

Published

on

By


Cannareporter writes….

The legalization of cannabis may be introduced in the Portuguese Parliament and there may be political will and consensus for the approval of this regulation to be faster. In the “March for Cannabis” Manifestation, members of various parties, power and opposition, participated and revealed that it may be in 2023 that the proposal for the legalization of cannabis will enter parliament.

The staircase of the Assembly of the Republic building brought together, after the demonstration that headed from Largo do Camões, the various participants of the March for Cannabis, convened by the Mothers for Cannabis Associative Movement. It was at a time dedicated to interventions that the possibility of legalizing cannabis in the near future in Portugal was unveiled by various political leaders.

According to Francisco Themudo, National Secretary for the Rights, Freedoms and Guarantees of Socialist Youth, who addressed those present, he reasoned that there may be will, but above all, the necessary political conditions to move towards a comprehensive regulation of cannabis.

The leader stated that “smoking is an act of freedom, and that we have the right to do it safely”, defending a legal framework where the cannabis plant is not illegal. Fabien Figueiredo, former deputy for the Bloco de Esquerda and proponent of the bill to legalize personal consumption in 2021 But if there were any doubts, confirmation that, in the corridors of São Bento, cannabis is more than just talk, came from the Deputy of the Liberal Initiative, Rodrigo Saraiva. To the participants, the deputy said that it could even be in 2023 that the parliament will receive some proposals for discussion, “already with some prior consensus”.

Read full report

https://cannareporter.eu/en/2023/04/02/legalization-in-portugal-may-advance-later-this-year-with-political-consensus/?mc_cid=c0a48fdbf5



Source link

Continue Reading

UK / EU Cannabis Compliance

Spain Reaches Agreement on Future 1% THC Hemp Regulation

Published

on

By


French cannabis media outlet Newsweed writes…

In the absence of agreement for immediate regulation of light cannabis in Spain, the Spanish Workers’ Party ( PSOE ) managed to get an initiative approved by Congress which opens the door to future cannabis regulation at less than 1% THC.

If the initial objective has been considerably reduced, the initiative will make it possible to develop a clear framework for « the production, marketing and consumption of » products derived from the entire hemp plant in Spain.

Finally regulate CBD hemp in Spain

The final text should regulate all aspects that affect the activities of the non-psychoactive cannabis production cycle, as well as regional legislation on agriculture, by developing more precisely the European directives for the cultivation of industrial hemp.

According to Lucía Muñoz, Member of the UP cited by Europa Press, « the ban on this non-narcotics cannabis is equivalent to the ban on non-alcoholic beer and undermines the competitiveness of Spanish agriculture. »

The text adopted by Congress launches work for the definition of a clear framework.

He therefore calls for « progress in promoting the regulation of industrial hemp in order to give legal certainty to production, the marketing and consumption of products derived therefrom, while respecting the powers of the autonomous regions and the principle of subsidiarity in terms of protecting public security, health and agriculture ».

Read the full article at 

https://www.newsweed.fr/espagne-accord-future-reglementation-chanvre-1-thc/?mc_cid=c0a48fdbf5



Source link

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media